Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03906214 · ClinicalTrials.gov registry record
Evidence-based Assessment of Medication Sensitivity in Acute Hepatic Porphyria
A clinical trial of Porphyrias, sponsored by University of South Florida.
- Completed
- Registry status
- 60
- Enrollment target
- 1
- Study location
NCT03906214: Completed study of Porphyrias, sponsored by University of South Florida.
NCT03906214 is a study of Porphyrias that has completed, run by University of South Florida. The registered enrollment target is 60 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03906214, a study of Porphyrias, has completed, sponsored by University of South Florida.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
This is an observational study collecting patient/caregiver reports on suspected medication/drug-induced acute porphyria attacks, as well as safe use of drugs previously labeled "unsafe" or with unknown risk. Participants will be recruited through the RDCRN Contact Registry for the Porphyrias Consortium. The study will be advertised on the Consortium website and through the American Porphyria Foundation's social media network.
Primary Outcome
Designed to capture PBG levels, characteristics of the acute attack, timing of medication administration, and pharmacological information on the medication.
Conditions Studied
Interventions
- OTHER Web-based Survey
Study Locations (1)
Florida
- University of South Florida Data Management Coordinating Center - Tampa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2019-04-03 |
| Est. Completion | 2019-09-13 |
What the finished NCT03906214 record still lists
NCT03906214 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.
The record links to 1 condition, with Porphyrias appearing as the primary indexed condition, and to 1 intervention - of which Web-based Survey is the first listed.
NCT03906214 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT03906214 about?
NCT03906214 is a clinical study titled "Evidence-based Assessment of Medication Sensitivity in Acute Hepatic Porphyria". This is an observational study collecting patient/caregiver reports on suspected medication/drug-induced acute porphyria attacks, as well as safe use of drugs previously labeled "unsafe" or with unknown risk. Participants will be recruited through the RDCRN Contact Registry for the Porphyrias Consor...
What is the current status of trial NCT03906214?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2019-04-03. Estimated completion is 2019-09-13.
What conditions does trial NCT03906214 study?
This clinical trial studies the following conditions: Porphyrias.
What interventions are being tested in trial NCT03906214?
The interventions under investigation include: Web-based Survey (OTHER).
Who is sponsoring clinical trial NCT03906214?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03906214 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI